Heat Biologics Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, has launched its wholly-owned subsidiary, Skunkworx Bio Inc., focused on the development of a drug discovery paradigm to enable rapid drug development.   Skunkworx’s proprietary libraries of “Pocket Biologics” are used to identify miniature proteins which bind to critical domains of druggable targets. The Skunkworx approach aims to enable rapid drug discov...